Rallybio Corp Quarterly Operating Income (Loss) in USD from Q2 2020 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Rallybio Corp quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q3 2024.
- Rallybio Corp Operating Income (Loss) for the quarter ending September 30, 2024 was -$12.1M, a 37.7% increase year-over-year.
- Rallybio Corp Operating Income (Loss) for the twelve months ending September 30, 2024 was -$70M, a 6.56% increase year-over-year.
- Rallybio Corp annual Operating Income (Loss) for 2023 was -$78.9M, a 16.3% decline from 2022.
- Rallybio Corp annual Operating Income (Loss) for 2022 was -$67.9M, a 48.7% decline from 2021.
- Rallybio Corp annual Operating Income (Loss) for 2021 was -$45.6M, a 80.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)